ライフサイエンスコーパス: electroshock

1 nvulsant against seizures induced by maximal electroshock.

2 eased threshold to tonic seizures induced by electroshock.

3 sses generalized seizures induced by maximal electroshock and pentylenetrazole.

4 nic stimulation in Fring's mice, and maximal electroshock and subcutaneous pentylenetetrazol (Metrazo

5 seizures and epilepsy, including the maximal electroshock- and 6 Hz-induced seizures, corneal kindlin

6 pe can be measured in larval stages using an electroshock assay, and this behavior in bs mutants is d

7 vulsants against seizures induced by maximal electroshock (ED50 = 41, 55, and 74 mg/kg, respectively)

8 ty (ED(50) = 8.4 mg/kg) in the mouse maximal electroshock epilepsy model.

9 d in mice for their ability to block maximal electroshock-induced convulsions and ATPA-induced rigidi

10 t anticonvulsant activity in a mouse maximum electroshock-induced seizure (MES) assay: the ED50 was 2

11 otency as anticonvulsants in a mouse maximal electroshock-induced seizure (MES) model.

12 th potent anticonvulsants in a mouse maximal electroshock-induced seizure (MES) study (ED(50) (iv) =

13 exhibit outstanding activity in the maximal electroshock-induced seizure (MES) test in rodents.

14 e taken for wandering larvae to recover from electroshock-induced seizure activity.

15 Mouse maximum electroshock-induced seizure studies show that the three

16 ntraperitoneal (i.p.) dosing for the maximal electroshock-induced seizure test for 18 and 19 were 8.3

17 osemide suppressed the occurrence of maximal electroshock-induced seizures in a dose-dependent manner

18 CYM2503 also attenuated electroshock-induced seizures in mice.

19 e via inhibition of its uptake protects from electroshock-induced seizures in the rat.

20 ificantly protected from death after maximum electroshock-induced seizures.

21 ements and suppressed the tonic component of electroshock-induced seizures.

22 oral anticonvulsant activity against maximal electroshock (MES) and subcutaneous metrazol (scMET) mod

23 s comparatively evaluated in the rat maximal electroshock (MES) and subcutaneous metrazol (scMet) sei

24 rogram for seizure protection in the maximal electroshock (MES) and subcutaneous Metrazol models.

25 g anticonvulsant activity in a mouse maximal electroshock (MES) assay.

26 lled seizures on the in vivo induced maximal electroshock (MES) model and thus gives sustainment of a

27 with antiseizure activity in the rat maximum electroshock (MES) model.

28 jected to acute seizure induction by maximal electroshock (MES) or pilocarpine, variably including el

29 prototypical AAA (safinamide) in the maximal electroshock (MES) seizure model in rats.

30 pronounced seizure protection in the maximal electroshock (MES) seizure test with activities similar

31 d animal seizure models, namely, the maximal electroshock (MES) test and the psychomotor 6 Hz (32 mA)

32 isingly high in vivo activity in the maximal electroshock (MES) test in mice.

33 clinical seizure models, namely, the maximal electroshock (MES) test, the subcutaneous pentylenetetra

34 y in the pentylenetetrazol (PTZ) and maximal electroshock (MES) tests following ip administration in

35 across in vivo mouse seizure models: maximal electroshock (MES), 6 Hz (32/44 mA), acute pentylenetetr

36 e suppression of tonic motor seizures in the electroshock model of epilepsy.

37 and the suppression of tonic seizures in the electroshock model of epilepsy.

38 2DG did not protect against maximal electroshock or Metrazol seizures.

39 nd quinoxalin-4-ones were active in an acute electroshock physical dependence side effect assay in mi

40 otent anticonvulsant activity in the maximal electroshock seizure (MES) test (ca. 8 times greater tha

41 e models, including a direct current maximal electroshock seizure assay.

42 ivities in animal models, and in the maximal electroshock seizure test the activity of (3'-trifluorom

43 dissect the multifactorial nature of maximal electroshock seizure threshold (MEST) in C57BL/6 (B6) an

44 Using the rat Maximal Electroshock Seizure Threshold (MEST) test, (S)-3,4-DCPG

45 to seizure-induced death, we induced maximal electroshock seizures in free-running C57BL/6J mice at d

46 rats by evoking multiple brief, noninjurious electroshock seizures.

47 nds were active in the mouse and rat maximal electroshock tests but not in the mouse metrazole test.

48 the glycine agonist d-serine, in the maximal electroshock threshold (MEST) test in the rat.

49 lsive shock (ECS) was used to assess maximal electroshock threshold (MET) in B6, D2 and hybrid mice.

50 s in freely moving rats subjected to maximal electroshock to simultaneously measure glucose, lactate,

51 The ability to associate odors with electroshock was abolished when Galphas* was targeted to